Recently clinicians at McMaster University in Hamilton, Ont., noticed that ulipristal acetate seemed to reduce pelvic pain in women who were taking it to shrink fibroids and reduce bleeding and other symptoms. They reviewed their records and found 18 women who formally rated their pain before and while on ulipristal acetate.
Evotec AG announced recently that it has reached a milestone from Bayer for the progression of a programme from the alliance portfolio into Phase I clinical development for the treatment of endometriosis. This news comes at a time triggering a milestone payment to Evotec.
Illinois-based AbbVie, in cooperation with Neurocrine Biosciences of San Diego, California, announced positive results from the second of two replicate Phase 3 clinical trials evaluating the efficacy and safety of their drug candidate Elagolix in premenopausal women who suffer pain from the gynecological disorder endometriosis.
Member since 2014
Founder, 2012
Member since 2012
